{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:38:13Z","timestamp":1789609093083,"version":"build-2803163510"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.transproceed.2021.11.022","type":"journal-article","created":{"date-parts":[[2021,12,30]],"date-time":"2021-12-30T16:12:55Z","timestamp":1640880775000},"page":"147-152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Refractory Acute Antibody Mediated Rejection in Liver Transplant After Desensitization of Preformed Donor Specific Antibody\u2014Validity of Bortezomib and Everolimus: A Case Report"],"prefix":"10.1016","volume":"54","author":[{"given":"Masahiko","family":"Komagome","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9413-0548","authenticated-orcid":false,"given":"Akira","family":"Maki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rihito","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Kogure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Mitsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riki","family":"Ninomiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhisa","family":"Akamatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2021.11.022_bib0001","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1111\/ajt.13909","article-title":"2016 Comprehensive update of the banff working group on liver allograft pathology: introduction of antibody-mediated rejection","volume":"16","author":"Demetris","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2021.11.022_bib0002","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/tri.12654","article-title":"De novo donor-specific anti-HLA antibodies mediated rejection in liver-transplant patients","volume":"28","author":"Del Bello","year":"2015","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2021.11.022_bib0003","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.humimm.2016.02.006","article-title":"Donor-specific antibodies and liver transplantation","volume":"77","author":"Del Bello","year":"2016","journal-title":"Hum Immunol"},{"key":"10.1016\/j.transproceed.2021.11.022_bib0004","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/lt.25663","article-title":"Outcome of liver transplant patients with preformed donor-specific anti-HLA antibodies","volume":"26","author":"Del Bello","year":"2020","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2021.11.022_bib0005","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1537-2995.1999.39199116901.x","article-title":"Prevalence of HLA sensitization in female apheresis donors","volume":"39","author":"Densmore","year":"1999","journal-title":"Transfusion"},{"key":"10.1016\/j.transproceed.2021.11.022_bib0006","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/hepr.13352","article-title":"Preformed donor-specific antibodies are associated with 90-day mortality in living-donor liver transplantation","volume":"49","author":"Tamura","year":"2019","journal-title":"Hepatol Res"},{"key":"10.1016\/j.transproceed.2021.11.022_bib0007","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4174\/astr.2015.88.2.100","article-title":"Effect of donor-specific antibodies and panel reactive antibodies in living donor liver transplant recipients","volume":"88","author":"Song","year":"2015","journal-title":"Ann Surg Treat Res"},{"key":"10.1016\/j.transproceed.2021.11.022_bib0008","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/lt.23788","article-title":"Antibody-mediated rejection as a contributor to previously unexplained early liver allograft loss","volume":"20","author":"O'Leary","year":"2014","journal-title":"Liver Transplant"},{"key":"10.1016\/j.transproceed.2021.11.022_bib0009","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/bmb\/ldv013","article-title":"Kidney transplantation in highly sensitized patients","volume":"114","author":"Jordan","year":"2015","journal-title":"Br Med Bull"},{"key":"10.1016\/j.transproceed.2021.11.022_bib0010","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.hbpd.2018.02.005","article-title":"A comparison of desensitization methods: Rituximab with\/without plasmapheresis in ABO-incompatible living donor liver transplantation","volume":"17","author":"Lee","year":"2018","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.transproceed.2021.11.022_bib0011","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/liv.13614","article-title":"A simplified protocol using rituximab and immunoglobulin for ABO-incompatible low-titre living donor liver transplantation","volume":"38","author":"Kim","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.transproceed.2021.11.022_bib0012","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.transci.2019.04.028","article-title":"Cascade plasmapheresis as a desensitization strategy for patients undergoing ABO incompatible living donor liver transplantation (ABOi LDLT): a single center experience","volume":"58","author":"Bajpai","year":"2019","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transproceed.2021.11.022_bib0013","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s00535-012-0530-2","article-title":"Living donor liver transplantation using sensitized lymphocytotoxic crossmatch positive graft","volume":"47","author":"Aoki","year":"2012","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.transproceed.2021.11.022_bib0014","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/lt.23694","article-title":"Liver transplantation with a strongly positive crossmatch: case study and literature review","volume":"19","author":"Leonard","year":"2013","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2021.11.022_bib0015","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1432-2277.2006.00447.x","article-title":"Treatment of antibody-mediated rejection with high-dose immunoglobulins in","volume":"20","author":"Urbani","year":"2007","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2021.11.022_bib0016","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.transproceed.2012.01.008","article-title":"Veno-occlusive disease\/sinusoidal obstruction syndrome associated with potential antibody-mediated rejection after pediatric living donor liver transplantation: a case report","volume":"44","author":"Yamada","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2021.11.022_bib0017","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.transproceed.2019.03.019","article-title":"Everolimus-based immunosuppression possibly suppresses mean fluorescence intensity values of de novo donor-specific antibodies after primary kidney transplantation","volume":"51","author":"Narumi","year":"2019","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2021.11.022_bib0018","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/ajt.12669","article-title":"Everolimus inhibits anti-HLA I antibody-mediated endothelial cell signaling, migration and proliferation more potently than sirolimus","volume":"14","author":"Jin","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2021.11.022_bib0019","doi-asserted-by":"crossref","first-page":"e491","DOI":"10.1097\/TXD.0000000000000932","article-title":"Bortezomib against refractory antibody-mediated rejection after ABO-incompatible living-donor liver transplantation: dramatic effect in acute-phase?","volume":"5","author":"Tajima","year":"2019","journal-title":"Transplant Direct"},{"key":"10.1016\/j.transproceed.2021.11.022_bib0020","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1111\/j.1600-6143.2012.04126.x","article-title":"Bortezomib for acute antibody-mediated rejection in liver transplantation","volume":"12","author":"Paterno","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2021.11.022_bib0021","doi-asserted-by":"crossref","first-page":"776","DOI":"10.2174\/1389203717666160226145101","article-title":"Humoral response in liver allograft transplantation: a review of the role of anti-human leukocyte antigen (HLA) antibodies","volume":"17","author":"Muro","year":"2016","journal-title":"Curr Protein Pept Sci"},{"key":"10.1016\/j.transproceed.2021.11.022_bib0022","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1111\/ajt.13749","article-title":"Functional immune anatomy of the liver\u2014as an allograft","volume":"16","author":"Demetris","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2021.11.022_bib0023","doi-asserted-by":"crossref","unstructured":"Kim H, Yi N-J, Song EY, et al. Preformed donor-specific antibodies do not affect the 1-year allograft survival in living donor liver transplantation. Clin Transplant 018;32:e13244.","DOI":"10.1111\/ctr.13244"},{"key":"10.1016\/j.transproceed.2021.11.022_bib0024","doi-asserted-by":"crossref","DOI":"10.1111\/petr.12791","article-title":"Acute antibody-mediated rejection in ABO-compatible pediatric liver transplant recipients: case series and review of the literature","volume":"21","author":"Wozniak","year":"2017","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.transproceed.2021.11.022_bib0025","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/MOT.0000000000000275","article-title":"Prevention and treatment of liver allograft antibody-mediated rejection and the role of the \u201ctwo-hit hypothesis","volume":"21","author":"Kim","year":"2016","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.transproceed.2021.11.022_bib0026","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1124\/jpet.108.144147","article-title":"Everolimus inhibits monocyte\/macrophage migration in vitro and their accumulation in carotid lesions of cholesterol-fed rabbits","volume":"328","author":"Baetta","year":"2009","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134521008812?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134521008812?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:40:28Z","timestamp":1758577228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134521008812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0041134521008812"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2021.11.022","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Refractory Acute Antibody Mediated Rejection in Liver Transplant After Desensitization of Preformed Donor Specific Antibody\u2014Validity of Bortezomib and Everolimus: A Case Report","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2021.11.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}